Effects of Polymorphisms in the Serotonin Transporter Promoter-Linked Polymorphic Region on Postthoracotomy Pain Severity
Aya Kimura,Hiroyuki Yamasaki,Haruka Ishii,Hisako Yoshida,Motoko Shimizu,Takashi Mori
DOI: https://doi.org/10.2147/JPR.S298685
IF: 2.8319
2021-05-25
Journal of Pain Research
Abstract:Aya Kimura, 1 Hiroyuki Yamasaki, 1 Haruka Ishii, 2 Hisako Yoshida, 2 Motoko Shimizu, 3 Takashi Mori 1 1 Department of Anesthesiology, Osaka City University Graduate School of Medicine, Osaka City, Osaka, Japan; 2 Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka City, Osaka, Japan; 3 Department of Anesthesiology, Sumitomo Hospital, Osaka City, Osaka, Japan Correspondence: Aya Kimura Department of Anesthesiology, Osaka City University Graduate School of Medicine, 1-5-7 Asahimachi, Abeno-ku, Osaka City, Osaka, 545-8586, Japan Tel +81-6-6645-2186 Fax +81-6-6645-2489 Email Purpose: Serotonin (5-HT) is highly associated with pain modulation. The human 5-HT transporter (5-HTT) gene (SLC6A4) features several polymorphisms in its promoter region (5-HTTLPR) that affect the 5-HTT expression. The S allele of 5-HTTLPR induces low 5-HT tone, and it may influence the modulation of chronic pain. Meanwhile, pain occurs in 40– 50% of patients after thoracic surgery, and its mechanism remains under investigation. This study assessed the role of 5-HTTLPR polymorphisms in postthoracotomy pain severity. Patients and Methods: A total of 178 patients undergoing pneumonectomy were enrolled. The genotypes of 5-HTTLPR were divided into two groups: S/S group and S/L or L/L group. Linear mixed-effects models were used to assess the association between 5-HTTLPR genotypes and the numerical rating scale (NRS) score change over time. Results: Among the participants, data were obtained for 162 patients. The genotype distribution was as follows: S/S, 67.3%; S/L or L/L, 32.7%. No significant difference in patient characteristics was found between the genotype groups. There was no significant interaction between the 5-HTTLPR genotypes and the NRS score change over time (p = 0.842). Conclusion: Polymorphisms in 5-HTTLPR were not associated with postthoracotomy pain severity. Keywords: 5-HTTLPR, pain modulation, numerical rating scale Persistent postsurgical pain is a significant problem for a large number of patients. It decreases patients' quality of life and increases their economic burden. Surgery is essential for serious diseases, but 10–80% of patients experience pain after various types of surgery. 1 , 2 The consequences vary widely among patients, causing both physical and mental disabilities. Thoracotomy has been described as a high-risk surgery that induces persistent postsurgical pain. 3 Postthoracotomy pain syndrome (PTPS) has been defined as pain lasting for >2 months after surgery by the International Association for Study of Pain. 4 A large number of studies have focused on the predictors of PTPS. 5 , 6 The risk factors for PTPS are classified into preoperative, intraoperative, and postoperative factors. Neuropathic changes after surgery have been demonstrated to be associated with chronic pain. 2 , 7 However, the underlying mechanism is highly complex. Preoperative conditions, especially genetic factors, have emerged as novel predictors of postoperative chronic pain. 8 , 9 The perception of pain varies among individuals, as it is a subjective experience influenced by combinations of factors such as sex, races, emotions, sensations, culture, and genes. 10–12 Genetic studies have therefore been conducted to demonstrate the mechanism of pain modulation in the central nervous system. Serotonin (5-hydroxytryptamine [5-HT]) is a neurotransmitter that is highly involved in the pain mechanism. 5-HT is associated with the modulation of nociceptive signals both through the peripheral and central nervous systems, and it regulates mood. 13 , 14 The 5-HT transporter (5-HTT) is an essential regulator of 5-HT that transfers the neurotransmitter from synapses to presynaptic neurons and terminates extracellular signaling. 5-HTT regulates the concentration of 5-HT and manages postsynaptic signaling. It has been revealed that the effectiveness of opioids depends on the 5-HTT genotype. 15 5-HTT in humans is encoded by SLC6A4, one of the most studied genes in the neurobiology field. The promoter region of the gene contains several polymorphisms, and this variation affects the expression of the 5-HTT gene. The polymorphic region consists of a 43-base pair insertion/deletion known as the 5-HTT–linked polymorp -Abstract Truncated-
clinical neurology